Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

alteplase

Known as: T-Plasminogen Activator, Tissue Activator D 44, TPA 
A recombinant therapeutic agent which is chemically identical to or similar to endogenous tissue plasminogen activator (tPA). tPA is a serine… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Numerous types of cancer have been shown to be associated with either ischemic or hemorrhagic stroke. In this review, the… Expand
  • table I
  • figure 1
  • figure 2
  • table II
Is this relevant?
Review
2019
Review
2019
BACKGROUND Stroke thrombolysis with alteplase is currently recommended 0-4·5 h after stroke onset. We aimed to determine whether… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2018
Review
2018
The objective of this comprehensive review is to summarize and discuss the available evidence of how adipose tissue inflammation… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
ACE : angiotensin-converting enzyme AF : atrial fibrillation aPTT : activated partial thromboplastin time AR : aortic… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Early administration of intravenous recombinant tissue plasminogen activator (rt-PA) after ischaemic stroke improves… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Summary Background Thrombolysis for acute ischaemic stroke has been investigated in several clinical trials, with variable… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
  • Koroshetz Wj
  • The New England journal of medicine
  • 1995
  • Corpus ID: 25812408
BACKGROUND Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND The relative efficacy of streptokinase and tissue plasminogen activator and the roles of intravenous as compared with… Expand
Is this relevant?